肺膜微病:一个病例报告和简要的文献综述
Reza Mohseni Ahangar1, Mohammad Golparvar Azizi2, Sara Babazadeh3
1Department of Internal Medicine, Babol University of Medical Sciences, Babol, Iran.
Caspian journal of internal medicine
|August 11, 2025
概括
肺膜微病 (PAM) 是一种罕见的肺部疾病,由SLC34A2的突变引起,导致酸的积累. 这个案例突出了诊断发现和文献审查,以提高临床医生的意识.
科学领域:
- 肺部医学 肺部医学
- 罕见疾病 罕见疾病
- 遗传学 是一个遗传学.
背景情况:
- 肺膜微病 (PAM) 是一种罕见的自体逆向性肺部疾病.
- 具有广泛的酸微石沉积在气泡中的特点.
- 由溶解物载体家族34成员2 (SLC34A2) 基因的突变引起,该基因编码的是IIb类型 (NPT2b) 的酸共运输体.
研究的目的:
- 报告一个偶发的肺膜微石病 (PAM) 病例.
- 通过叙事文献综述来澄清PAM的不同方面.
- 提高临床医生的意识,改善PAM的诊断.
主要方法:
- 对于最初的怀疑,进行胸部X射线.
- 高分辨率计算机断层扫描 (HRCT) 用于详细的成像.
- 经支气管肺活检用于组织学确认.
主要成果:
- 一名50岁的男性出现症状,包括喉痛,发烧和出汗.
- 放射学发现显示了双边的微节点形状与磨砂玻璃衰减.
- 组织学检查证实了膜内结石,导致了PAM的诊断.
结论:
- 一个零星的PAM病例是使用成像和活检来诊断的.
- 这项研究旨在提高临床医生对PAM的认识.
- 早期和准确的诊断对于管理这种罕见的肺部疾病至关重要.
相关概念视频
Pulmonary Tuberculosis II
2.5K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
2.5K
Atelectasis II: Pathophysiology
75
Atelectasis develops when alveoli lose their air and collapse inward. Because lung tissue is naturally elastic, these air sacs shrink rather than remaining open. Collapsed alveoli are no longer ventilated, reducing their role in gas exchange. Blood flow may continue in these regions, creating a ventilation–perfusion mismatch. Clinical findings include decreased breath sounds, dullness to percussion, reduced chest expansion, and decreased tactile fremitus as sound transmission through...
75
Chronic Obstructive Pulmonary Disease I: Introduction
71
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
71
Chronic Obstructive Pulmonary Disease II: Emphysema
155
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
155
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
77
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
77


